PLASMA LEVODOPA LEVEL AND CSF DOPAMINE L-DOPA RATIO IN SEVERELY DISABLED PARKINSONIAN-PATIENTS

被引：0

作者：

TAKATAS, A

TARCZY, M

HARSING, L

BIHARI, K

CSANDA, E

机构：

来源：

NEW TRENDS IN CLINICAL NEUROPHARMACOLOGY: CALCIUM ANATONISTS, ACUTE NEUROLOGY, HEADACHE AND MOVEMENT DISORDERS | 1988年 / 7卷

关键词：

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：286 / 288

页数：3

共 50 条

[41] CIRCADIAN SECRETION PATTERN OF MELATONIN IN DE-NOVO PARKINSONIAN-PATIENTS - EVIDENCE FOR PHASE-SHIFTING PROPERTIES OF L-DOPA
FERTL, E
AUFF, E
DOPPELBAUER, A
WALDHAUSER, F
JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1993, 5 (03) : 227 - 234
[42] CARDIOPRESSOR EFFECTS OF SHORT-TERM TREATMENT WITH CABERGOLINE IN L-DOPA STABLE RESPONDER PARKINSONIAN-PATIENTS - RELEVANCE OF POSTPRANDIAL HYPOTENSION
CAVALLINI, A
MICIELI, G
MARTIGNONI, E
BLANDINI, F
FARIELLO, R
NAPPI, G
CLINICAL NEUROPHARMACOLOGY, 1991, 14 (04) : 343 - 351
[43] THE EFFECT OF CARBIDOPA ON PLASMA AND MUSCLE LEVELS OF L-DOPA, DOPAMINE, AND THEIR METABOLITES FOLLOWING L-DOPA ADMINISTRATION TO RATS
ROSE, S
JENNER, P
MARSDEN, CD
MOVEMENT DISORDERS, 1988, 3 (02) : 117 - 125
[44] INTELLECTUAL AND MEMORY FUNCTION IN PARKINSONIAN AND NON-PARKINSONIAN PATIENTS TREATED WITH L-DOPA
DONNELLY, EF
CHASE, TN
DISEASES OF THE NERVOUS SYSTEM, 1973, 34 (02): : 119 - 123
[45] SIMULTANEOUS MEASUREMENT OF L-DOPA, ITS METABOLITES AND CARBIDOPA IN PLASMA OF PARKINSONIAN-PATIENTS BY IMPROVED SAMPLE PRETREATMENT AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION
LUCARELLI, C
BETTO, P
RICCIARELLO, G
GIAMBENEDETTI, M
CORRADINI, C
STOCCHI, F
BELLIARDO, F
JOURNAL OF CHROMATOGRAPHY, 1990, 511 : 167 - 176
[46] In vivo assessment of Intrasynaptic dopamine in Parkinson patients following treatment with L-dopa or L-dopa/entacapone
Seibyl, JP
Tabamo, R
Jennings, D
Tamagnan, G
Rabinowicz, A
Marek, K
MOVEMENT DISORDERS, 2005, 20 : S44 - S45
[47] Apomorphine SC treatment in parkinsonian patients with long term L-DOPA syndrome during L-DOPA drug holiday
Scarzella, L
Delsedime, M
Ferrero, B
Giangrandi, C
Priano, L
Rizzone, M
Bergamasco, B
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1995, (45): : 163 - 170
[48] PLASMA L-DOPA IN THE DIAGNOSIS OF PATIENTS WITH MELANOMA
CAMP, VM
MURRAY, DR
FARAJ, BA
JOURNAL OF NUCLEAR MEDICINE, 1984, 25 (05) : P10 - P10
[49] Calcium homeostasis is dysregulated in parkinsonian patients with L-Dopa induced dyskinesias
Blandini, F.
Bazzini, E.
Marino, F.
Saporiti, F.
Armentero, M. -T.
Pacchetti, C.
Zangaglia, R.
Martignoni, E.
Lecchini, S.
Nappi, G.
Cosentino, M.
MOVEMENT DISORDERS, 2008, 23 (01) : S88 - S88
[50] MECHANISM OF NULLIFICATION OF CNS EFFECTS OF L-DOPA BY PYRIDOXINE IN PARKINSONIAN PATIENTS
PFEIFFER, R
EBADI, M
JOURNAL OF NEUROCHEMISTRY, 1972, 19 (09) : 2175 - +

← 1 2 3 4 5 →